STI/RTI | 15–24 years | 25–49 years | Total |
---|---|---|---|
Number of participants | |||
1999 | 78 | 98 | 176 |
2002–04 | 1467 | 1187 | 2654 |
HSV-2 | |||
1999 | 26.9% | 41.8% | 35.2% |
2002–04 | 28.9% | 38.8% | 33.5% ↔ |
Syphilis | |||
1999 | 1.3% | 5.1% | 3.4% |
2002–04 | 0.5% | 1.3% | 0.9% ↓ |
Gonorrhoea | |||
1999 | 1.3% | 0.0% | 0.6% |
2002–04 | 0.6% | 0.4% | 0.5% ↔ |
Trichomoniasis | |||
1999 | 26.0% | 21.4% | 23.4% |
2002–04 | 5.4% | 4.6% | 5.0% ↓ |
Bacterial vaginosis | |||
1999 | 26.0% | 35.7% | 31.4% |
2002–04 | 23.4% | 17.7% | 20.9% ↓ |
Any curable STI/RTI † | |||
1999 | 41.6% | 51.0% | 46.9% |
2002–04 | 27.2% | 21.7% | 24.7% ↓ |